Paradigm Diagnostics
Phoenix, US · Founded 2016 · Delaware corporation · 1 known investors
Founders & leadership
SM
Scott MorrisExecutive
DN
David NealExecutive
GC
Grace ColonNamed on SEC filing
DM
David MalleryNamed on SEC filing
EC
Erin CurleyNamed on SEC filing
CN
Carey NgNamed on SEC filing
RA
Robert ArmknechtNamed on SEC filing
RM
Rodney MarkinNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$11M disclosed across 1 round · 2016
▶$11MraisedDec 2018 · 12 investors · PharmaceuticalsRule 506(b)
▶$11MraisedDec 2018 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Grace ColonDirector
- Scott MorrisExecutive Officer
- David NealExecutive Officer
- David MalleryExecutive Officer, Director
- Erin CurleyDirector
- Carey NgDirector
- Robert ArmknechtDirector
- Rodney MarkinDirector
- Offering amount
- $12.5M
- Amount sold
- $11M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Paradigm Diagnostics's investors?
- Paradigm Diagnostics's investors include OSF Ventures.
- How much funding has Paradigm Diagnostics raised?
- Paradigm Diagnostics has disclosed $11M raised across 1 round.
- Where is Paradigm Diagnostics headquartered?
- Paradigm Diagnostics is headquartered in Phoenix, US.